Startup Raises $55M for World’s First Robotic Cataract Surgery
Startup Raises $55M for World’s First Robotic Cataract Surgery ForSight Robotics, is developing its robotic platform to treat a wide range of retinal conditions Robotic eye surgery startup ForSight Robotics has completed its series A funding round with a total investment of $55 million to advance its robotic surgical platform ORYOM. Named after the Hebrew word for “daylight,” ORYOM would be the first platform of its kind to offer entirely robotic cataract surgery. It uses microsurgical robotics, computer visualization, and machine learning and has already been successfully used in multiple cataract procedures on an animal eye model by a number of ophthalmic surgeons. According to ForSight, ORYOM shows 10 times the accuracy of human surgeons doing the same procedure. The funds raised will be used to accelerate ORYOM through clinical trials, and allow ForSight to expand its platform’s offerings to treat a wider range of retinal diseases, such as glaucoma. The company also hopes to bring these procedures to people with typically limited access to healthcare; to address this current disparity. “Our goal is to democratize this highly sophisticated approach,” said ForSight CEO Dr. Daniel Glozman. “… Give patients around the world easy access to treatments that can restore their sight.” The latest round of funding was led by Adani Group along with existing investors Eclipse Ventures and Mithril Capital. Several new investors, including Provenio Capital, Precision Capital, Reiya Ventures, and Ljungstrom Family Office. Other important private investors also participated in the round.